Board of Directors

Glen Tullman

Glen Tullman

Executive Chairman
Glen Tullman is the Executive Chairman of Livongo and is passionately committed to finding a cure for diabetes and other chronic conditions and keeping people healthy until we do. A visionary leader and entrepreneur, he previously ran two public companies that changed the way healthcare is delivered. Most recently, Tullman served as Chief Executive Officer of Allscripts, the leading provider of Electronic Health Records, Practice Management and Electronic Prescribing systems. He is the author of On Our Terms: Empowering the New Health Consumer, which proposes new solutions to address the chronic-condition epidemic facing our country. A strong proponent of philanthropy, Tullman also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a Board member of the American Diabetes Association.
Zane Burke

Zane Burke

Chief Executive Officer

Zane Burke is the Chief Executive Officer of Livongo. Burke previously spent five years as president of Cerner Corporation, a $5.1 billion publicly-traded healthcare IT company where he worked for more than two decades transforming healthcare around the globe and building relationships with the top health systems in the world. While there, Burke held various senior executive roles in sales, strategy, finance, and operations. He also led direction and strategy around solutions and services, new business efforts, revenue generation, policy, federal involvement and marketing. With a wide range of expertise and tenure across sales, support and finance roles, Burke leads with an integrated business mind-set and a continuous focus on client relationships across all segments of the healthcare market. Burke sits on the Boards of the College of Healthcare Information Management Executives and Truman Medical Centers. He earned his undergraduate degree and MBA from Kansas State University

Chris Bischoff

Chris Bischoff

Senior Investment Director, Kinnevik
Chris Bischoff is Senior Investment Director of Kinnevik (NASDAQOMX:KINV), an industry focused investment company with an entrepreneurial spirit at its heart. Chris leads the investment team and concentrates on investing in disruptive and technology-enabled businesses across the healthcare, financial services and e-commerce sectors. Chris also serves on the board of Babylon Health, Betterment, Cedar Inc, and Quikr. Chris has previously served on the boards of Avito, Bayport and BIMA. Chris is based in Kinnevik’s London office.
Karen L. Daniel

Karen L. Daniel

Former Division President and Chief Financial Officer of Black & Veatch Corporation
Karen L. Daniel retired in July 2018 as Executive Director, Division President and Chief Financial Officer of the Global Finance and Technology Solutions division for Black & Veatch, a global leader in providing engineering, consulting and construction services for Energy, Water, and Telecommunication Sectors. As CFO, she was responsible for leading the company’s global financial operations that included treasury, tax, accounting, financial reporting, budgeting and financial systems, and establishing corporate financial policies. Ms. Daniel also led the company’s global IT organization, which included oversight of systems, technology development and associated service providers. Ms. Daniel currently serves on the Boards of Directors of Commerce Bancshares Inc., Snap-On Tools, and Blue Cross Blue Shield of Kansas City. She is also the past Chairwoman of the Greater Kansas City Chamber of Commerce. She holds a Bachelor of Science degree in Accounting from Northwest Missouri State University and a Master of Science degree in Accounting from the University of Missouri-Kansas City.
Sandra Fenwick

Sandra Fenwick

Chief Executive Officer, Boston Children’s Hospital
Sandra L. Fenwick is Chief Executive Officer of Boston Children's Hospital where she leads the nation's foremost independent pediatric hospital and the world's leading center of pediatric medical and health research. She has been a driving force to improve the effectiveness and efficacy of the care provided at Boston Children’s, while at the same time reducing the cost of care. Ms. Fenwick joined Boston Children’s in 1999 as Senior Vice President and was appointed Chief Operating Officer that year. She was named President in 2008 and was appointed Chief Executive Officer in 2013. Boston Children’s is a Harvard teaching hospital with more than $2.6 billion of annual revenue including $385 million of research funding. Boston Children’s has 1,600 physicians, trains more than 1,000 residents and fellows annually, and has more than 12,000 employees. Ms. Fenwick currently serves on the boards of directors of Harvard’s Wyss Institute for Biologically-inspired Engineering, Children’s Hospital Association, Greater Boston Chamber of Commerce, CRICO, Ltd., Massachusetts Digital Health Council, and Boston Children’s Hospital. She is also a member of the Massachusetts Women’s Forum and Women Corporate Directors/Boston. She holds a Bachelor’s degree from Simmons College with distinction and a Master’s in Public Health degree in Health Services Administration from the University of Texas School of Public Health. She has received numerous awards and honorary degrees for her contributions to healthcare.
Philip D. Green

Philip D. Green

President, PDG Consulting, LLC
Philip D. Green is President of PDG Consulting, LLC, a Washington, D.C.-based health care consulting firm. His clients include major academic medical centers, health care systems, community hospitals, individual physicians, group practices, physician associations, managed care enterprises, health insurers, lenders, and investors involved with health industry projects, equipment suppliers, clinical laboratories, manufacturers of drugs and devices, home health agencies, and various other health care-related enterprises. Mr. Green develops structures, negotiates, and implements innovative and strategic business ventures for his health care clients. Since 1976, Mr. Green has represented clients in a variety of fields, including health industry mergers and acquisitions, corporate planning and transactions, and litigation. Before forming PDG Consulting, Mr. Green was Senior Vice President, UPMC, and President, Strategic Business Initiatives (SBI), of the University of Pittsburgh Medical Center (UPMC). Mr. Green was directly responsible for all of UPMC’s strategic partnerships and relationships with for-profit companies. SBI is responsible for bringing new concepts and emerging technologies to market. Before joining UPMC, Mr. Green was Of Counsel at the law firm of Drinker Biddle & Reath, LLC, a partner at the law firms of Gardner Carton & Douglas and Akin Gump Strauss Hauer & Feld LLP, and a founding principal at Green, Stewart, Farber & Anderson, P.C. Mr. Green was born in Washington, D.C. He received his Bachelor of Science degree from the University of Pennsylvania in 1971, and his J.D. from the George Washington University in 1974.
Hemant Taneja

Hemant Taneja

Managing Director, General Catalyst
Hemant Taneja is a managing director at General Catalyst. He joined the firm in 2001 and launched its Silicon Valley office in 2011. Hemant’s investment thesis, known as “economies of unscale,” describes the belief that small, tightly focused companies can leverage web services, datasets, and AI to successfully launch and compete against much larger, more established competitors. His current investment portfolio ranges across several industries and includes companies such as ClassDojo, Color Genomics, Digit, Grammarly, Gusto, Fractyl, Fundbox, Livongo Health, Samsara, Snap, Stripe, ThoughtSpot and TuneIn. In addition to his investments, Hemant serves on the Stanford School of Medicine Board of Fellows, is the co-founder of Advanced Energy Economy, an organization focused on transforming energy policy in America and is a board member of Khan Lab School, a non-profit educational organization. He teaches a course on A.I., Entrepreneurship and Society at Stanford University and is slated to publish his first book, UNSCALED, that explores topics of technology and society in March 2018.